SOD1 and amyotrophic lateral sclerosis: In the present study, we show that CRISPR/Cas9-mediated gene-editing is an effective strategy to target hSOD1, leading to a disease-free condition in two distinct hSOD1-G93A transgenic mouse models (G1H and G1L) of ALS.